A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol-Myers Squibb Co. Champions Health Equity and Innovation, Securing Top Industry Recognition and Advancing Psychiatry and Immunology Treatments
Published: May 18, 2024 by Industry Intelligence Inc.
Bristol-Myers Squibb Co. Champions Pharmaceutical Innovation and Patient-Centric Care in Sweden, Advances Lung Cancer Research, and Supports Melanoma Awareness and Cancer Care in Italy
Published: May 17, 2024 by Industry Intelligence Inc.
Australia Patent: NAVIRE PHARMA, BRISTOL-MYERS SQUIBB File Application for 'COMBINATION THERAPY USING A PTPN11 INHIBITOR AND A KRAS G12C INHIBITOR'
Published: May 17, 2024 by Australian Government
Australia Patent: NAVIRE PHARMA, BRISTOL-MYERS SQUIBB File Application for 'COMBINATION THERAPY USING A PTPN11 INHIBITOR AND A KRAS G12C INHIBITOR'
Published: May 17, 2024 by Australian Government
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
Published: May 16, 2024 by Bristol-Myers Squibb Co.

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count